For Medical Professionals

Industry News

DNA research offers clues on cell mutation
1/07/2016

A team of researchers from Colorado State University has been studying DNA damage in living cells to learn more about how genetic abnormalities arise.

Less prostate cancer screening may delay treatment for earlier onset cancers
1/07/2016

More advanced cancers are being found in fewer needle biopsies, say investigators.The U.S.

Proposed link between liver cancer and adeno-associated virus challenged in Human GeneTherapy
1/07/2016

The conclusion drawn from a recent study that insertion of adeno-associated virus 2 (AAV2) into human DNA causes mutations leading to the development of hepatocellular carcinoma (HCC) was...

Fluorescent agent could help surgeons remove all of tumor first time
1/07/2016

An injectable agent that causes cancer cells to fluoresce could help surgeons remove all of a tumor the first time and prevent further operations and potentially cancer recurrence.

Scientists root out the 'bad seeds' of liver cancer
1/07/2016

USC researchers have discovered the Achilles' heel of hepatocellular carcinoma, the third-deadliest cancer.

Skin bacteria help cancer cells grow
1/07/2016

Our skin is covered in millions of bacteria and most of them help keep us healthy.

Effects of cancer screening on overall mortality overstated, says report
1/07/2016

While the general public hold the view that cancer screening reduces mortality, a new report claims studies have never shown that screening can reduce overall mortality.

Effective prevention of chronic graft versus host disease by anti-lymphocyte globulin after stem cell transplantation
1/06/2016

A European Group for Blood and Marrow Transplantation (EBMT) labeled phase III clinical trial has found that the addition of anti-lymphocyte globulin (ATG) as part of the conditioning regimen in...

Transgene announces first patient randomized in multinational Phase 3 trial for Pexa-Vec oncolytic immunotherapy in advanced liver cancer
1/06/2016

Transgene S.A. has announced the initiation of a multinational, randomized Phase 3 open label study with the oncolytic immunotherapy, Pexa-Vec, in patients with advanced liver cancer, also known as...

Association for Cancer Physicians releases cancer patient strategy for UK
1/06/2016

The Association for Cancer Physicians (ACP), which represents and supports medical oncologists in the UK, has published a new Strategy for improving cancer patient services and outcomes.